Literature DB >> 16463672

Expression of RECK gene and MMP-9 in hilar cholangiocarcinoma and its clinical significance.

Yiqing Li1, Yong Zhang, Qichang Zheng.   

Abstract

In order to study the expression of transformation suppressor gene RECK and MMP-9 in hilar cholangiocarcinomas and its clinical significance, and explore the roles of RECK gene in metastasis and invasion of hilar cholangiocarcinoma, the expression levels of RECK, and MMP-9 mRNA were detected by using reverse transcription-polymerase reaction in 42 paraffin-embedded samples of hilar cholangiocarcinomas and 10 samples of benign bile duct diseases. The results showed that in hilar cholangiocarcinoma tissues, the expression of RECK gene was 0.235 +/- 0.062, significantly lower than in normal bile duct tissues (0.533 +/- 0.024, P < 0.05). In hilar cholangiocarcinoma tissues, the expression of MMP-9 (0.528 +/- 0.039) was significantly higher than in the normal tissues (0.311 +/- 0.032, P < 0.05). The expression of RECK gene was closely related to the intrahepatic and surrounding organs invasion (P < 0.05). It was concluded that RECK gene could inhibit the expression of MMP-9 in hilar cholangiocarcinomas and closely correlated with the biological behaviors. The abnormal expression of RECK gene might be one of the molecular mechanisms of hilar cholangiocarcinoma metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16463672     DOI: 10.1007/BF02896015

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene.

Authors:  R M Sasahara; C Takahashi; M Noda
Journal:  Biochem Biophys Res Commun       Date:  1999-11-02       Impact factor: 3.575

2.  The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.

Authors:  J Oh; R Takahashi; S Kondo; A Mizoguchi; E Adachi; R M Sasahara; S Nishimura; Y Imamura; H Kitayama; D B Alexander; C Ide; T P Horan; T Arakawa; H Yoshida; S Nishikawa; Y Itoh; M Seiki; S Itohara; C Takahashi; M Noda
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

3.  [Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma].

Authors:  Hyo Jung Kim; Jae Seon Kim; Chang Don Kang; Sung Joon Lee; Jin Yong Kim; Jong Eun Yeon; Jong-Jae Park; Jae Jeong Shim; Kwan Soo Byun; Young-Tae Bak; Chang Hong Lee
Journal:  Korean J Gastroenterol       Date:  2005-01

Review 4.  Putting tumours in context.

Authors:  M J Bissell; D Radisky
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

5.  The ratio of MMP-2 to TIMP-2 in hilar cholangiocarcinoma: a semi-quantitative study.

Authors:  Mei Xiao; Nin-Xing Zhou; Zhi-Qiang Huang; Ya-Li Lu; Ling-Hong Chen; Dian-Jun Wang; Wei-Lin Chang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-11

6.  RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.

Authors:  Toshihiko Masui; Ryuichiro Doi; Takatomo Koshiba; Koji Fujimoto; Shoichiro Tsuji; Sanae Nakajima; Masayuki Koizumi; Eiji Toyoda; Sidhartha Tulachan; Daisuke Ito; Kazuhiro Kami; Tomohiko Mori; Michihiko Wada; Makoto Noda; Masayuki Imamura
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

7.  Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.

Authors:  C Takahashi; Z Sheng; T P Horan; H Kitayama; M Maki; K Hitomi; Y Kitaura; S Takai; R M Sasahara; A Horimoto; Y Ikawa; B J Ratzkin; T Arakawa; M Noda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

8.  Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.

Authors:  Paul N Span; C G J Sweep; Peggy Manders; Louk V A M Beex; David Leppert; Raija L P Lindberg
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

  8 in total
  8 in total

1.  Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus.

Authors:  Xuan Zhang; Caitlin Healy; Warren B Nothnick
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

2.  Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.

Authors:  N Namwat; J Puetkasichonpasutha; W Loilome; P Yongvanit; A Techasen; A Puapairoj; B Sripa; W Tassaneeyakul; N Khuntikeo; S Wongkham
Journal:  J Gastroenterol       Date:  2010-11-13       Impact factor: 7.527

3.  High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma.

Authors:  Qi Sun; Chuanzong Zhao; Leizhou Xia; Zhaobin He; Zhihua Lu; Chuan Liu; Ming Jia; Jiayong Wang; Jun Niu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.

Authors:  Qi Sun; Fanni Li; Fengkai Sun; Jun Niu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

5.  Reversion-inducing cysteine-rich protein with Kazal motifs gene expression and its clinical significance in peripheral T-cell lymphoma.

Authors:  Xia Mao; Longlong Liu; Bing Zhang; Donghua Zhang
Journal:  Oncol Lett       Date:  2013-04-16       Impact factor: 2.967

6.  Effect of RECK gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.

Authors:  Tsung-Te Chung; Chao-Bin Yeh; Yi-Ching Li; Shih-Chi Su; Ming-Hsien Chien; Shun-Fa Yang; Yi-Hsien Hsieh
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

7.  RECK Gene Polymorphism is Associated with Susceptibility and Prognosis of Wilms' Tumor in Chinese Children.

Authors:  Yang Yu; Yuanjun Hu; Kaisheng Li; Zhihong Chen; Hongmei Zhang; Lei Zhang
Journal:  Med Sci Monit       Date:  2015-07-03

Review 8.  Molecular Markers in the Pathogenesis of Cholangiocarcinoma: Potential for Early Detection and Selection of Appropriate Treatment.

Authors:  Cornelia Braicu; Claudia Burz; Ioana Berindan-Neagoe; Ovidiu Balacescu; Marcel Tantau; Victor Cristea; Alexandru Irimie
Journal:  Gastroenterology Res       Date:  2009-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.